CiVentiChem, a 30-year-old contract development and manufacturing organization (CDMO) with roots in North Carolina, has completed building a new facility in Hyderabad, India, expanding its ...

Sage Therapeutics, a Boston-area biopharmaceutical company, has declared Raleigh its “second home” by opening a groundbreaking patient-support headquarters here called Sage Central. That was the ...

North Carolina Agricultural and Technical State University and Merck (NYSE: MRK), known as MSD outside of the United States ...

CSL Seqirus, a global vaccine maker with a massive manufacturing plant in Holly Springs, has received two federal grants ...

The NC CRO Collaborative Career Fair will provide students and job seekers the opportunity to learn more about clinical research careers and network with leading employers. Denise started work at Duke ...

Locus Biosciences is a fast-emerging North Carolina biotechnology company that’s about to get a lot faster at unfolding its Pac-Man-like genetic tricks to whack drug-resistant bacteria. The Research ...

Alcami Corp., a contract development and manufacturing organization (CDMO) headquartered in Durham and with major operations in Wilmington, has expanded its drug-making capacity by acquiring TriPharm ...

Pancreatic cancer is an elusive and deadly disease. It often has no initial symptoms, and there are no reliable tests for early detection. The mortality rate is 75 percent within a year of diagnosis, ...

The North Carolina Biotechnology Center has announced the inaugural class of Pfizer-NCBiotech Distinguished Postdoctoral Fellows in Gene Therapy. The Fellows include Adrian Pickar and Hye Ri Kang of ...

AveXis, an Illinois-based clinical-stage company developing gene therapies for neurological genetic diseases, is investing $55 million in a new Durham manufacturing facility that will create 200 jobs.

The latest company loans awarded by the North Carolina Biotechnology Center in the fourth quarter of FY 2016 bring to 189 the number of North Carolina bioscience companies that have received funding ...